跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 64 条关于
“EP0028”
全部
64
临床试验
32
药物
26
机构
0
资讯
6
7个月前
Ellipses In-Licenses First-in-Class B7H3 Antibody Drug Conjugate from Innolake Biopharm
12个月前
Kelun-Biotech's Next-Generation RET Inhibitor A400/EP0031 Receives NDA Acceptance in China for NSCLC Treatment
去年
Ellipses Pharma Launches First Phase 1/2 Oncology Trial in the UAE with RET Inhibitor EP0031/A400
去年
FDA Approves IND for FP008, a Novel PD-1×IL-10M Fusion Protein for Resistant Solid Tumors
去年
Fapon Biopharma Enrolls First Patient in Phase I Trial of FP008, Novel Anti-PD-1 Fusion Protein for Solid Tumors
3个月前
Dual-Target Gene Therapy BBM-P002 Shows Clean Phase 1 Safety in Parkinson's, But Regulatory Path Remains Uncharted